endocrine · Mechanism Report
FSHB rs10835638 T allele is associated with lower circulating FSH levels in women.
The FSHB rs10835638 T allele is associated with decreased circulating follicle-stimulating hormone (FSH) levels in women.
This is what AI claimed
The FSHB rs10835638 T allele is associated with higher circulating follicle-stimulating hormone levels in women.
Executive summary
Contrary to the claim that the T allele increases FSH, genetic and functional evidence indicate the T allele reduces FSHB promoter activity and lowers gene expression, leading to decreased FSH secretion. This reduced FSH production is linked to reproductive effects such as longer menstrual cycles and a later age at natural menopause.
Verified conclusion
The relationship between the FSHB rs10835638 variant and follicle-stimulating hormone (FSH) production is well-established in genomic research. However, the evidence indicates that the direction of the effect for the T allele is the opposite of what was claimed.
Clinical and genomic evidence
Large-scale genome-wide association studies (GWAS) and clinical cohorts have consistently identified the rs10835638 T allele (specifically the c.-211G>T variant) as a potent FSH-lowering variant. In female populations, carrying the T allele is robustly associated with decreased serum FSH levels across various stages of the reproductive lifespan.
- Effect Direction: Quantitative data from biobank studies (such as the UK Biobank) show that the T allele correlates with lower circulating FSH concentrations rather than higher levels.
- Reproductive Impact: Because it reduces FSH levels, this variant is associated with clinically significant reproductive phenotypes, including longer menstrual cycles and a later age at natural menopause.
- Disease Associations: Due to its FSH-lowering properties, the T allele has been identified as a protective factor against conditions driven by high estrogen or FSH-driven follicular recruitment, such as endometriosis and polycystic ovary syndrome (PCOS).
Mechanistic explanations
The rs10835638 polymorphism is located within the promoter region of the FSHB gene, which encodes the specific β-subunit of the follicle-stimulating hormone.
- Transcriptional Activity: The T allele functions as a regulatory variant that reduces the transcriptional activity of the FSHB promoter. In vitro reporter assays demonstrate that the G-to-T substitution decreases the promoter's ability to drive gene expression.
- Protein Synthesis: The reduction in FSHB mRNA expression leads directly to a decrease in the synthesis and secretion of the FSH protein by the anterior pituitary gland.
- LH Interactions: Interestingly, while it lowers FSH, the T allele has been associated with compensatory or independent increases in luteinizing hormone (LH) levels in some contexts, but its primary effect on the FSHB gene remains inhibitory.
Bottom line
The FSHB rs10835638 T allele is associated with lower circulating FSH levels in women, not higher. By reducing the transcriptional output of the FSHB gene, this variant leads to decreased hormone production, which clinically manifests as delayed reproductive aging and altered risk for gynecological conditions.
References
- FSHB promoter polymorphism within evolutionary conserved element is associated with serum FSH level in men — academic.oup.com
- FSHB promoter polymorphism within evolutionary conserved element is associated with serum FSH level in men — pmc.ncbi.nlm.nih.gov
- Genetic evidence that lower circulating FSH levels lengthen menstrual cycle, increase age at menopause and impact female reproductive health — pmc.ncbi.nlm.nih.gov
- O-089 A Genome Wide Association Study in men with unexplained infertility identifies nine SNPs at the FSHB locus to be associated with Follicle Stimulating Hormone level — academic.oup.com
- Pharmacogenetics of follicle-stimulating hormone action — pmc.ncbi.nlm.nih.gov
- Genetic evidence that lower circulating FSH levels lengthen menstrual cycle, increase age at menopause and impact female reproductive health — academic.oup.com
See a full patient report verified like this
Book a walkthrough